Objective
to investigate the clinical outcomes of patients with NSTEMI treated with drug-coated balloon as compared to BMS or DES stent implantation
Study
multicentre, randomised non-inferiority trial
Population
patients with NSTEMI
Endpoints
TLF as combined death, re-infarction and TL revascularisation at 9 months
Conclusion
Conclusion: treatment of patients with NSTEMI with drug-coated balloons was non-inferior to treatment with BMS or DES
Scheller et al. EuroIntervention 2020;15:1527-33
